News · CD6

09/07/2015

Francisco J. Burgos awarded with OSA Outstanding Student Contribution Award

In the last edition of the National Optics Meeting held in Salamanca, CD6 PhD candidate Francisco J. Burgos received the ... [+info]

06/12/2015

Current Concepts in Amblyopia: What We’ve Learned From 18 Years of the Amblyo...

Amblyopia is responsible for more vision loss for people under age 45 than all other causes combined. Unfortunately, good, evidence-based ... [+info]

06/01/2015

A photonics based biosensor with plasmonic accuracy and low cost

The proof of concept proposed is aimed at the healthcare market, and in particular to portable medical devices (lab-on-chip) and microfluidics. ... [+info]

04/28/2015

Assessment of multifocal contact lens over-refraction using an infrared, open-fi...

CD6 researchers recently published a study on the use of an infrared open-field autorefractor to predict refractive error when fitting a ... [+info]

04/20/2015

5th edition of the knowledge Fair of Berga

CD6 took part in the 5th Knowledge Fair of Berga, which took place on 15th and 16th April in the ... [+info]

04/16/2015

Foveal vision: the role of microsaccades in fixation and discrimination

On Tuesday April 21st, the DRC-UPC organizes the seminar "Foveal vision: the role of microsaccades in fixation and discrimination" taught ... [+info]

02/04/2015

Speckle reduction in double-pass retinal images using variable-focus lenses

CD6 researchers have published a new method for reducing the Speckel pattern present in the retinal images obtained using the ... [+info]

01/14/2015

EOS conference on Optomechanical Engineering

CD6 is chairing the first EOS conference on Optomechanical Engineering, to be held next 22-25 of June in Munich, held ... [+info]

11/18/2014

Seminar: Machine Learning for data analysis and visualization

Under the project DAVALOR, CD6 organizes a seminar titled "Machine Learning for data analysis and visualization" taught by Dr. Jesus ... [+info]

11/15/2014

The MEGACOPT Project

Based on the studies previsously committed to CD6, in 2012 DAVALOR SALUD, SL started the design and development of a ... [+info]